Overall survival and sequential treatment of patients with metastatic breast cancer treated by German office-based medical oncologists – outcome data from the TMK Registry.

Tesch, H., Däßler, K., Müller-Hagen, S., Kruggel, L., Jänicke, M., Marschner, N., 2013.

Onkologie 36 (suppl 7)(V358), 98. doi:10.1159/000356365

Studie: TMK; Indikation: Mammakarzinom; Jahr: 2013; Veranstaltung: DGHO; Journal: Onkologie

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com